Evidence map›Paper›PMID 25237398›Full record

ArticleThyroid research2014

Prevalence of diabetes mellitus in patients with newly evaluated papillary thyroid cancer.

Yannis M Paulus, Elyn R Riedel, Mona M Sabra, Robert Michael Tuttle, Marcia F Kalin

Abstract read
In one paragraph

Article in Thyroid research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes.The Journal of clinical endocrinology and metabolism · 2019
    Article
  6. Review
  7. Soft tissue invasion of papillary thyroid carcinoma.Clinical & experimental metastasis · 2016
    Article
  8. Diabetes, Diabetes Treatment, and Risk of Thyroid Cancer.The Journal of clinical endocrinology and metabolism · 2016
    Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yannis M PaulusMemorial Sloan-Kettering Cancer Center, Department of Medicine, 1275 York Avenue, New York, NY 10065, USA.
Elyn R RiedelMemorial Sloan-Kettering Cancer Center, Department of Epidemiology and Biostatistics, 1275 York Avenue, Box 313, New York, NY 10065, USA.
Mona M SabraMemorial Sloan-Kettering Cancer Center, Department of Medicine, 1275 York Avenue, New York, NY 10065, USA.
Robert Michael TuttleMemorial Sloan-Kettering Cancer Center, Department of Medicine, 1275 York Avenue, New York, NY 10065, USA.
Marcia F KalinMemorial Sloan-Kettering Cancer Center, Department of Medicine, 1275 York Avenue, New York, NY 10065, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study investigates whether diabetes mellitus is a risk factor for the development of papillary thyroid cancer, using an age-, gender-, and race-matched analysis.

methodsWe retrospectively reviewed the charts of 1559 patients with newly evaluated thyroid cancer over a 4-year period at our institution and identified 1313 patients (84%) with papillary thyroid carcinoma. Characteristics of patients with diabetes versus those without diabetes were compared with a chi-square test for categorical variables and the Wilcoxon Rank Sum test for numeric variables. The prevalence of diabetes among patients with papillary thyroid carcinoma at our institution was compared (using an age-, gender-, and race-matched analysis) with that expected based on data from the continuous National Health and Nutrition Examination Survey (NHANES) from the same time period.

resultsFor patients with papillary thyroid carcinoma, the median age was 47 years; 74% were female; 83% were white; and the prevalence of diabetes was 8%. Among those with diabetes, 92% had type 2 diabetes, and 24% were treated with insulin. Risk factors for diabetes included age and race. The prevalence of diabetes among patients with papillary thyroid carcinoma of all ages versus that among patients from NHANES of all ages was not significantly different (RR 1.07, CI 0.88 - 1.28). The prevalence of diabetes among patients with papillary thyroid cancer who were 44 years of age or younger versus that among patients from NHANES who were 44 years of age or younger, however, was significantly increased (RR 2.32, CI 1.37 - 3.66). There was no significant difference when subgroup analysis was performed by gender or race.

conclusionsWe found an increased prevalence of diabetes in patients with papillary thyroid carcinoma who were 44 years of age or younger.

Indexed as

Diabetes mellitusNHANESPapillary thyroid cancerRisk factor

Identifiers

PMID25237398
PMCPMC4167256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.